Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug

[MEDPAGE TODAY]( Oncology Update Friday, December 08, 2023 [Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug]( [Milestone Gene Therapies for Sickle Cell Disease Greenlit by FDA]( [FDA Approves Oral Factor B Inhibitor for Paroxysmal Nocturnal Hemoglobinuria]( [More Awareness Needed of Heart Events Tied to Breast Cancer Drugs, Experts Say]( [GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients]( [OPINION]( [Doing More With Less Blood]( ADVERTISEMENT Exclusives & Features [Corporate Ownership Worsens Patient Care, Surveyed Docs Say]( [Blood Test May Be Able to Tell Which Organs Have Accelerated Aging]( [Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.]( PURPOSE: Primary mediastinal large B-cell lymphoma (PMBCL) is a rare aggressive lymphoma predominantly affecting young female patients. Large-scale genomic investigations and genetic markers for risk... [READ MORE]( [Engine Capital pushes for changes at cancer therapy developer 2seventy bio]( Activist investor Engine Capital on Wednesday sent a letter to the board of cancer therapy developer 2seventy bio , urging a board refresh and the appointment of its chief operating officer Chip... [READ MORE]( [Cancer Evolution: A Multifaceted Affair.]( UNLABELLED: Cancer cells adapt and survive through the acquisition and selection of molecular modifications. This process defines cancer evolution. Building on a theoretical framework based on... [READ MORE]( [Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.]( BACKGROUND: Although the associations between genetic variations and lung cancer risk have been explored, the epigenetic consequences of DNA methylation in lung cancer development are largely... [READ MORE]( [New gene therapies confront many sickle cell patients with an impossible choice: a cure or fertility]( Lack of coverage for fertility services will be a huge obstacle for people eager to try Casgevy or a second sickle cell cure awaiting U.S. approval. [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-12-08&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011